Beta Bionics BBNX
NASDAQ BBNX
$17.42 -1.91 (-9.88%)
As of: Sep 9, 2026 · 3:59 PM EDT

Beta Bionics (BBNX) Price to Book (2025 - 2026)

Beta Bionics' (BBNX) quarterly Price to Book came in at 2.75 in Q2 2026, up 31.04% year-over-year from 2.1 in Q2 2025, and up 67.02% quarter-over-quarter from 1.65 in Q1 2026.

Analysis

Beta Bionics (BBNX) Price to Book (2025 - 2026) Analysis & Trends

Beta Bionics has disclosed Price to Book across 2 years of filings, most recently posting 2.75 for Q2 2026.

  • In Q2 2026, Price to Book rose 31.04% year-over-year to 2.75; the TTM figure through Jun 2026 stood at 2.75 (up 31.04% YoY), while the FY2025 annual figure was 4.7, changed N/A from the prior year.
  • Price to Book came in at 2.75 for Q2 2026 at Beta Bionics, up from 1.65 in the prior quarter.
  • In the past five years, Price to Book ranged from a high of 4.7 in Q4 2025 to a low of 1.2 in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn
10 Beta Bionics 873.54 Mn 693.05 Mn 18.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.75
Mar 31, 2026 1.65
Dec 31, 2025 4.70
Sep 30, 2025 2.97
Jun 30, 2025 2.10
Mar 31, 2025 1.20